It was a single in-vitro screen at 10 M (a concentration that may sit well above what a 5 mg dose produces in your tissues), so it is not proof you are taking an MAOI
The EFSA notes, The inherent uncertainty of this [factorial] approach is reflected in the wide range of cobalamin intake calculated to compensate for estimated daily losses, depending on the assumptions taken (EFSA, 2015). Appendix D
Side Effects and Safety Both AOD 9604 and Semaglutide are generally considered safe, but they have different side effect profiles: AOD 9604 : This peptide has minimal reported side effects in clinical studies, making it a safer option for individuals who are sensitive to traditional growth hormone therapy
For individuals who want to avoid pharmaceuticals or who hit a plateau on diet/exercise alone, this peptide duo offers a hormone-boosting strategy to push past stubborn set points
Peptide-fragment structure research
The peptide is not a fast-acting intervention